Skip to main content
. 2022 Aug 7;28(29):3946–3959. doi: 10.3748/wjg.v28.i29.3946

Table 1.

Clinical characteristics of hypertriglyceridemic acute pancreatitis

Characteristic
All (n = 371)
Sex, n (%)
Male 247 (66.6)
Female 124 (33.4)
Age, yr 39.86 ± 10.20
BMI (kg/m2) 25.99 ± 3.18
Causes, n (%) 203 (54.7)
Diet (high fatty acid) 127 (34.2)
Drinking (beer) 55 (14.8)
Mixed 21 (5.7)
Complications, n (%)
Diabetes mellitus 115 (31.0)
Hypertension 62 (16.7)
Fatty liver disease 336 (90.6)
Pregnancy 11 (3.0)
Recurrence, n (%) 122 (32.9)
Grades of severity, n (%)
MAP 63 (17.0)
MSAP 208 (56.1)
SAP 100 (26.9)
Improved Marshall score 1.30 ± 1.77
Organ failure, n (%) 117 (31.5)
MCTSI score 5.00 ± 1.83
Lipid-lowering treatment, n (%)
Intravenous insulin 144 (38.8)
HP 32 (8.6)
CRRT/HP + CRRT 77 (20.8)
Only anti-lipemic 118 (31.8)
Baseline TG, mg/dL 2544.59 ± 2305.37
Baseline AMY (nUNL) 5.00 ± 6.47
> UNL, n (%) 297 (80.1)
≥ 3UNL, n (%) 174 (46.9)
Admission to ICU, n (%) 126 (34.0)
Death, n (%) 11 (3.0)

BMI: Body mass index; MAP: Mild acute pancreatitis; MSAP: Moderately severe acute pancreatitis; SAP: Severe acute pancreatitis; MCTSI: Modified computed tomography severity index; HP: Hemoperfusion; CRRT: Continuous renal replacement therapy; TG: Triglyceride; AMY: Amylase; UNL: Upper limit of normal; ICU: Intensive care unit.